
Fibromyalgia
Pertinent History
Symptoms: Widespread soft tissue pain, fatigue, unrefreshing sleep, "fibrofog" (poor concentration)
Associated Conditions: Mood disorders (anxiety, depression), irritable bowel/bladder symptoms
Chronicity: Symptoms persist ≥3 months
Examination
Tenderness: Soft tissue points (e.g., lateral condyles, trapezius)
Allodynia: Pain with light touch or BP cuff inflation
Normal Findings: Joint and systemic exam normal
Diagnosis
Criteria (ACR 2010/2016):
Widespread Pain Index (WPI) ≥7 and Symptom Severity Score (SSS) ≥5 OR
WPI 3–6 and SSS ≥9
No alternative explanation for symptoms
Labs/imaging only to exclude other causes
____________________________________
Management
Non-Pharmacological:
Exercise: Gradual aerobic or hydrotherapy-based programmes
Psychological: CBT and mindfulness for pain coping/stress
Sleep Hygiene: Fixed schedule, minimise disturbances
Support: Refer to fibromyalgia support groups, multidisciplinary input
Pharmacological:
First Line: Low-dose TCAs (e.g., amitriptyline 10–25 mg nocte)
Second Line: Duloxetine or pregabalin (dose titration based on tolerance)
Avoid Opioids: Except tramadol in specialist contexts
Goal: Improve functionality, not eliminate pain
Counselling Points
Pain is real but not due to tissue damage
Symptoms may fluctuate; condition is not progressive
Treatment aims to improve function, not eliminate pain
Emphasise adherence to long-term management
Red Flags
New onset in older age
Focal pain or neurological signs
Systemic symptoms: Weight loss, fever, night sweats
May indicate alternative pathology
When to Refer
Atypical presentation or refractory symptoms
Significant psychosocial or psychological comorbidities
Differentials
Rheumatoid arthritis (RA)
Polymyalgia rheumatica (PMR)
Chronic fatigue syndrome (CFS)
Hypothyroidism
Sleep apnoea
Complications
Functional impairment, diminished quality of life
Secondary depression and anxiety
Notes
Overlap: Often coexists with RA, SLE, or other chronic illnesses
First-line drug: Low-dose TCAs (improve sleep and pain)
If TCAs fail: Consider gabapentinoid or SNRI (duloxetine)
Bookmark Failed!
Bookmark Saved!